On Monday, Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) was -6.36% drop from the session before settling in for the closing price of $2.36. A 52-week range for MRVI has been $2.07 – $11.56.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 42.54% over the past five years. When this article was written, the company’s average yearly earnings per share was at -154.72%. With a float of $116.77 million, this company’s outstanding shares have now reached $141.98 million.
Let’s look at the performance matrix of the company that is accounted for 570 employees. In terms of profitability, gross margin is 39.14%, operating margin of -90.29%, and the pretax margin is -100.89%.
Maravai LifeSciences Holdings Inc (MRVI) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Maravai LifeSciences Holdings Inc stocks. The insider ownership of Maravai LifeSciences Holdings Inc is 18.71%, while institutional ownership is 85.72%. The most recent insider transaction that took place on Jan 31 ’25, was worth 125,750. In this transaction General Counsel of this company sold 25,000 shares at a rate of $5.03, taking the stock ownership to the 167,618 shares. Before that another transaction happened on Jan 31 ’25, when Company’s Officer proposed sale 25,000 for $5.03, making the entire transaction worth $125,750.
Maravai LifeSciences Holdings Inc (MRVI) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -154.72% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 8.57% during the next five years compared to -64.27% drop over the previous five years of trading.
Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) Trading Performance Indicators
You can see what Maravai LifeSciences Holdings Inc (MRVI) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 6.65. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.17.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.03, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.19 in one year’s time.
Technical Analysis of Maravai LifeSciences Holdings Inc (MRVI)
Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) saw its 5-day average volume 2.72 million, a negative change from its year-to-date volume of 3.28 million. As of the previous 9 days, the stock’s Stochastic %D was 37.47%. Additionally, its Average True Range was 0.24.
During the past 100 days, Maravai LifeSciences Holdings Inc’s (MRVI) raw stochastic average was set at 2.25%, which indicates a significant decrease from 21.88% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 63.92% in the past 14 days, which was lower than the 112.61% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.69, while its 200-day Moving Average is $6.44. Nevertheless, the first resistance level for the watch stands at $2.30 in the near term. At $2.40, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.45. If the price goes on to break the first support level at $2.15, it is likely to go to the next support level at $2.10. The third support level lies at $2.00 if the price breaches the second support level.
Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) Key Stats
There are 254,336K outstanding shares of the company, which has a market capitalization of 562.08 million. As of now, sales total 259,190 K while income totals -144,850 K. Its latest quarter income was 56,410 K while its last quarter net income were -26,150 K.
